首页 >
法规速递
-
关于公开征求《抗体偶联放射性核素药物药学研究与评价技术指导原则（征求意见稿）》意见的通知-2026/4/13
2026-04-14查看详情 > -
Page: SME Regulation and reports-2026/5/28
2026-05-29查看详情 > -
Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research Guidance for Industry(Final)-2023/01/23
2023-01-23查看详情 > -
国家药监局药审中心关于办公地址搬迁有关事宜的通知-2023/7/31
2023-08-02查看详情 > -
国家药监局综合司公开征求《中药标准管理专门规定（征求意见稿）》意见-2024/2/5
2024-03-12查看详情 > -
Document: List of centrally authorised products with safety-related changes to the product information-2025/1/31
2025-02-05查看详情 > -
Document: Minutes of the Cancer Medicines Forum - December 2024-2025/3/11
2025-03-12查看详情 > -
Document: Superseded - Composition of the Emergency Task Force (ETF) for preparedness-2025/4/11
2025-04-13查看详情 > -
Document: Timetable: Type IB variation requiring linguistic review-2025/5/23
2025-05-26查看详情 > -
Page: Tadalafil product-specific bioequivalence guidance-2025/6/30
2025-07-01查看详情 >
